Abstract
To measure parent knowledge levels and opinions related to the human papillomavirus (HPV) and the two vaccines used to prevent it. To measure parent behavior in terms of whether or not to have their children vaccinated. Between June 19, 2012, and August 24, 2012, questionnaires were distributed to parents while waiting for their child to see their pediatrician at a local group practice. The survey was reviewed for face validity by College of Pharmacy social science and clinical faculty members, and an earlier version of it had been used successfully in a published study of biomedical students’ knowledge of and attitudes toward the HPV vaccine. 129 usable surveys were obtained. 48.1 % of subjects said they learned about the HPV vaccines from the media, while 47.3 % identified health care practitioner(s) as a source of knowledge. The mean score on a 20-item knowledge test regarding the infection and vaccines was 36 % (range 0–80 %). Opinions on the subject varied widely. For example, 22.4 % of subjects agreed that schools should require that students be vaccinated before enrolling, while 3.2 % agreed that vaccination causes patients to become sexually active. Subjects reported vaccination status for 253 children (mean age 13) as follows: 33 % vaccinated; 28 % not vaccinated but will be; 11 % will never be vaccinated; and 28 % not decided. These results are somewhat encouraging, because many parents are hearing about the vaccines from their providers. Although not an equally valid source, the media are also raising awareness. Based on the knowledge and opinion results of this study, there is a need for pharmacists and other providers to educate their patients about the vaccines and the virus and to converse with them regarding the moral and psychological implications of vaccination. Still, it is encouraging that these subjects had or plan to have over half (61 %) of their children vaccinated.
Similar content being viewed by others
References
Trottier, H., & Fanco, E. L. (2006). Human papillomavirus and cervical cancer: Burden of illness and basis for prevention. The American Journal of Managed Care, 12(17; suppl), S462–S472.
Woodman, C. B., Collins, S. I., & Young, L. S. (2007). The natural history of cervical HPV infection: Unresolved issues. Nature Reviews Cancer, 7(1), 11–22.
Markowitz, L. E., Dunne, E. F., Saraiya, M., et al. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). Morbidity and mortality weekly report. Recommendations and Reports, 56(RR-2), 1–24.
Reisinger, K. S., Block, S. L., Lazcano-Ponce, E., et al. (2007). Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6,11,16,18 L1 virus-like particle vaccine in preadolescents and adolescents: A randomized control trial. The Pediatric infectious disease journal, 26(3), 201–209.
Winer, R. L., Feng, Q., Hughes, J. P., O’Reilly, S., Kiviat, N. B., & Koutsky, L. A. (2008). Risk of female human papillomavirus acquisition associated with first male sex partner. Journal of Infectious Diseases, 197(2), 279–282.
Gardasil [package insert]. (2009). Whitehouse Station, NJ: Merck & Co, Inc.
Cervarix [package insert]. (2010). Research Triangle Park, NC:GlaxoSmithKine.
www.cdc.gov/vaccines/who/teens/vaccines/hpv.html, accessed 2 Dec 2011.
www.MDConsult.com. Human Papillomavirus Vaccine, Quadrivalent. accessed 9 Dec 2009.
www.fda.gov/consumer/updates/gardasil092908.html, accessed 9 Dec 2008.
Hutchinson, D. J., & Klein, K. C. (2008). Human papillomavirus disease and vaccines. American Journal of Health-System Pharmacy, 65(22), 2105–2112.
Luedtke, S. (2008). Human papillomavirus vaccine: Are the concerns unfounded? American Journal of Health-System Pharmacy, 65(22), 2150–2151.
http://www.cdc.gov/vaccines/vpd-vac/hpv/vac-faqs.htm, accessed 21 Jun 2013.
http://www.cdc.gov/vaccines/programs/vfc/cdc-vac-price-list.htm, accessed 21 Jun 2013.
http://www.illinoishealthywomen.com/covered.html, accessed 21 Jun 2013.
Tsau, K., Reutzel, T., Wang, S., Quiñones, A., Nguyen, P., Hasan, S., et al. (2011). The knowledge levels and opinions of biomedical students regarding the human papillomavirus quadrivalent (types 6, 11, 16, and 18) recombinant vaccine. Journal of Pharmacy Practice, 24(2), 223–234.
Reutzel, T., Desai, A., Workman, G., Atkin, J., Grady, S., Todd, T., et al. (2008). Medication management in primary and secondary schools: Evaluation of mental health related in-services in locals schools. The Journal of School Nursing, 24, 239–248.
Stephen, J. W., & Paul, R. T. (1993). Indicators and predictors of health services utilization. In J. W. Stephen & R. T. Paul (Eds.), Introduction to health services (4th ed., pp. 53–55). Albany, NY: Delmar Publishers.
Rosenstock, I. M. (1974). Historical origins of the health belief model. Health Education Monographs, 2, 344.
Darden, P. M., Thompson, D. M., Roberts, J. R., et al. (2013). Reasons for not vaccinating adolescents: National immunization survey of teens, 2008–2010. Pediatrics, 131(4), 648–649.
Acknowledgments
This research was supported by a Pilot Grant from the Midwestern University Chicago College of Pharmacy Research Grant Program funded by the University’s Office of Research and Sponsored Programs. Ms. Grabiel’s work was supported by a Chicago College of Pharmacy Student Research Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grabiel, M., Reutzel, T.J., Wang, S. et al. HPV and HPV Vaccines: The Knowledge Levels, Opinions, and Behavior of Parents. J Community Health 38, 1015–1021 (2013). https://doi.org/10.1007/s10900-013-9725-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10900-013-9725-6